» Articles » PMID: 9136903

Maurotoxin, a Four Disulfide Bridge Toxin from Scorpio Maurus Venom: Purification, Structure and Action on Potassium Channels

Overview
Journal FEBS Lett
Specialty Biochemistry
Date 1997 Apr 14
PMID 9136903
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

A new toxin acting on K+ channels, maurotoxin (MTX), has been purified to homogeneity from the venom of the chactoid scorpion Scorpio maurus. MTX is a basic single chain 34 amino acid residue polypeptide, amidated at its C terminal, and crosslinked by four disulfide bridges. It shows 29-68% sequence identity with other K+ channel toxins, and presents an original disulfide pattern, the last two half-cystine residues (31-34) being connected. Although the first three disulfide bonds have not been defined experimentally, modelling based on the structure of charybdotoxin favored two combinations out of six, one of which has two bridges (3-24 and 9-29) in common with the general motif of scorpion toxins. The last bridge would connect residues 13 and 19. MTX inhibits the binding to rat brain synaptosomal membranes of both [125I]apamin, a SK(Ca) channel blocker (IC50 5 nM), and [125I]kaliotoxin, a Kv channel blocker (IC50 30 pM). MTX blocks the Kv1.1, Kv1.2 and Kv1.3 currents expressed in Xenopus oocytes with IC50 of 45, 0.8 and 180 nM, respectively. MTX represents a member of a new class of short toxins with 4 disulfide bridges, active on voltage-dependent K+ channel and also competing with apamin for binding to its receptor.

Citing Articles

Structure-Function Relationship of a Novel MTX-like Peptide (MTX1) Isolated and Characterized from the Venom of the Scorpion .

ElFessi R, Khamessi O, De Waard M, Srairi-Abid N, Ghedira K, Marrouchi R Int J Mol Sci. 2024; 25(19).

PMID: 39408804 PMC: 11477167. DOI: 10.3390/ijms251910472.


Of Seven New K Channel Inhibitor Peptides of , α-KTx 2.24 Has a Picomolar Affinity for Kv1.2.

Shakeel K, Olamendi-Portugal T, Naseem M, Becerril B, Zamudio F, Delgado-Prudencio G Toxins (Basel). 2023; 15(8).

PMID: 37624263 PMC: 10467108. DOI: 10.3390/toxins15080506.


Recombinant Expression in System of Three Potent Kv1.3 Channel Blockers: Vm24, Anuroctoxin, and Ts6.

Borrego J, Naseem M, Sehgal A, Panda L, Shakeel K, Gaspar A J Fungi (Basel). 2022; 8(11).

PMID: 36422036 PMC: 9697831. DOI: 10.3390/jof8111215.


Kv1.3 Channel as a Key Therapeutic Target for Neuroinflammatory Diseases: State of the Art and Beyond.

Wang X, Li G, Guo J, Zhang Z, Zhang S, Zhu Y Front Neurosci. 2020; 13:1393.

PMID: 31992966 PMC: 6971160. DOI: 10.3389/fnins.2019.01393.


N-linked glycosylation of Kv1.2 voltage-gated potassium channel facilitates cell surface expression and enhances the stability of internalized channels.

Thayer D, Yang S, Jan Y, Jan L J Physiol. 2016; 594(22):6701-6713.

PMID: 27377235 PMC: 5108895. DOI: 10.1113/JP272394.